Le TNF-α dans la physiopathologie du psoriasis - Inserm
Le TNF-α dans la physiopathologie du psoriasis - Inserm
Le TNF-α dans la physiopathologie du psoriasis - Inserm
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A. ROZIERES, F. BERARD, J.-F. NICOLAS<br />
26. Groves RW, Allen MH, Ross EL, Barker JN, MacDonald DM. Tumour<br />
necrosis factor alpha is pro-inf<strong>la</strong>mmatory in normal human skin and<br />
mo<strong>du</strong><strong>la</strong>tes cutaneous adhesion molecule expression. Br J Dermatol 1995;<br />
132:345-52.<br />
27. Victor FC, Gottlieb AB. <strong>TNF</strong>-alpha and apoptosis: implications for<br />
the pathogenesis and treatment of <strong>psoriasis</strong>. J Drugs Dermatol 2002;1:<br />
264-75.<br />
28. Schottelius AJ, Moldawer LL, Dinarello CA, Asa<strong>du</strong>l<strong>la</strong>h K, Sterry W,<br />
Edwards CK, 3rd. Biology of tumor necrosis factor-alpha – implications<br />
for <strong>psoriasis</strong>. Exp Dermatol 2004;13:193-222.<br />
29. Iversen L, Johansen C, Kragballe K. Signal trans<strong>du</strong>ction pathways in<br />
human epidermis. Eur J Dermatol 2005;15:4-12.<br />
30. Zollner TM, Podda M, Pien C, Elliott PJ, Kaufmann R, Boehncke WH.<br />
Proteasome inhibition re<strong>du</strong>ces superantigen-mediated T cell activation<br />
and the severity of <strong>psoriasis</strong> in a SCID-hu model. J Clin Invest 2002;<br />
109:671-9.<br />
31. Nickoloff BJ. The immunologic and genetic basis of <strong>psoriasis</strong>. Arch<br />
Dermatol 1999;135:1104-10.<br />
32. Wakefield PE, James WD, Sam<strong>la</strong>ska CP, Meltzer MS. Tumor necrosis<br />
factor. J Am Acad Dermatol 1991;24:675-85.<br />
33. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB.<br />
Efficacy and safety of infliximab monotherapy for p<strong>la</strong>que-type <strong>psoriasis</strong>:<br />
a randomised trial. Lancet 2001;357:1842-7.<br />
180<br />
Ann Dermatol Venereol<br />
2006;133:174-80<br />
34. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CE.<br />
Cytokines and chemokines in the initiation and regu<strong>la</strong>tion of epidermal<br />
Langerhans cell mobilization. Br J Dermatol 2000;142:401-12.<br />
35. Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha<br />
(<strong>TNF</strong> alpha) in epidermal keratinocytes revealed using global transcriptional<br />
profiling. J Biol Chem 2004;279:32633-42.<br />
36. Pastore S, Mascia F, Mariotti F, Dattilo C, Girolomoni G. Chemokine<br />
networks in inf<strong>la</strong>mmatory skin diseases. Eur J Dermatol 2004;14:203-8.<br />
37. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM,<br />
Giannetti A et al. Keratinocytes from patients with atopic dermatitis and<br />
<strong>psoriasis</strong> show a distinct chemokine pro<strong>du</strong>ction profile in response to<br />
T cell-derived cytokines. J Allergy Clin Immunol 2001;107:871-7.<br />
38. Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G.<br />
T cell clones from <strong>psoriasis</strong> skin lesions can promote keratinocyte<br />
proliferation in vitro via secreted pro<strong>du</strong>cts. Eur J Immunol 1994;24:593-8.<br />
39. Koch F, Heufler C, Kampgen E, Schneeweiss D, Bock G, Schuler G.<br />
Tumor necrosis factor alpha maintains the viability of murine epidermal<br />
Langerhans cells in culture, but in contrast to granulocyte/macrophage<br />
colony-stimu<strong>la</strong>ting factor, without in<strong>du</strong>cing their functional maturation.<br />
J Exp Med 1990;171:159-71.<br />
40. Theoharides TC, Done<strong>la</strong>n JM, Papadopoulou N, Cao J, Kempuraj D,<br />
Conti P. Mast cells as targets of corticotropin-releasing factor and re<strong>la</strong>ted<br />
peptides. Trends Pharmacol Sci 2004;25:563-8.